MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. ROCE Ratio 2011-2026 | PRAH
Annual ROCE Ratio PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 9.75 | 14.51 | 13.87 | 11.07 | 12.79 | 9.71 | 3.21 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.51 | 3.21 | 10.7 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 201.41 | -0.81 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 87.87 | -0.77 % | $ 4.11 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.05 | -5.71 % | $ 5.39 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.19 | $ 18.82 | 0.74 % | $ 579 M | USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 20.98 | 1.35 % | $ 608 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.64 | 2.19 % | $ 7.26 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
440.3 | $ 132.35 | 0.55 % | $ 16.6 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 23.83 | 3.74 % | $ 1.27 B | USA |
 |
Illumina
ILMN
|
29.64 | $ 166.13 | 3.21 % | $ 25.8 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
4.82 | $ 147.98 | 1.23 % | $ 11.6 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 161.11 | 2.62 % | $ 23.9 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-119.91 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
-9.11 | $ 11.21 | 0.54 % | $ 1.44 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 18.77 | -0.11 % | $ 420 M | USA |
 |
Natera
NTRA
|
-18.1 | $ 216.16 | 1.93 % | $ 29.6 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 104.54 | 0.02 % | $ 7.06 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 190.24 | 1.46 % | $ 9.43 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.39 | 5.81 % | $ 417 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 468.22 | 0.19 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.32 | -0.23 % | $ 400 M | USA |
 |
Personalis
PSNL
|
-33.71 | $ 10.25 | 6.88 % | $ 915 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.74 | 1.06 % | $ 25.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.31 | 1.74 % | $ 305 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 81.92 | 7.55 % | $ 4.9 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.01 | -1.95 % | $ 4.62 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 264.57 | -0.6 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 474.8 | 1.26 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.67 | 2.52 % | $ 241 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.22 | 1.26 % | $ 2 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |